In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation

Authors: Maria Angelica Cortez, David Valdecanas, Sharareh Niknam, Heidi J Peltier, Lixia Diao, Uma Giri, Ritsuko Komaki, George A Calin, Daniel R Gomez, Joe Y Chang, John Victor Heymach, Andreas G Bader, James William Welsh

Source: Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)

Subject Terms: miR-34a, non-small-cell lung cancer, RAD51, radiation, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2162253116300567; https://doaj.org/toc/2162-2531

Access URL: https://doaj.org/article/1d4cc5d09bf64a3f8a6b6dcc5d3c7696

INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.

Authors: Kathryn Mason, David Valdecanas, Nancy Hunter, Luka Milas

Source: Investigational New Drugs; Feb2008, Vol. 26 Issue 1, p1-5, 5p, 1 Chart, 2 Graphs

Subject Terms: LIGASES, POLYMERASE chain reaction, DOXORUBICIN, RESPONSE inhibition